J9259 Paclitaxel protein-bound particles (American Regent)

Effective July 1, 2023: J9259

(Injection, paclitaxel protein-bound particles (american regent)

not therapeutically equivalent to J9264, 1 mg)¹

-American Regent's Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) was approved under FDA's 505(b)(2) pathway and assigned NDC 00517-4300-01.

-As of July 1, 2023, the HCPCS Code assigned to this product is J9259.

-The HCPCS Code J9264 should not be used for this product.

-Please ensure the correct code is used in all relevant systems.

00517-4300-01 should be aligned to J9259

HCPCS Code	J9259
HCPCS Code Descriptor	Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to J9264, 1 mg¹
NDC Number	00517-4300-01
Package Description	100 mg/vial; single-dose vial
HCPCS Billing Units in Package	100
ASP (12/1/2023)	$15.31
WAC per HCPCS (12/1/2023)	$15.75

We respectfully request the update of all claims and reimbursement systems to include the HCPCS code: J9259 aligned to the NDC 00517-4300-01.

View Billing and Coding Guide Here

View Full Prescribing Information Here

References:

“HCPCS Quarterly Update.” CMS.gov. Accessed December 20, 2023. https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update.

December 2023 PP-PT-US-0024